To evaluate the efficacy of leuc capsule in leucorrhoea

SINGLE ARMED CLINICAL STUDY TO EVALUATED EFFICACY OF LEUC CAPSULE IN LEUCORRHOEA

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/06/053378

Enrollment

Registered

2023-06-01

Start date

Unknown

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N899- Noninflammatory disorder of vagina, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients having any complaint of discharge per vagina, Itching sensation at vulva, Burning sensation in vagina, Pain in vagina, Foul smell from vagina , backache and pelvic pain.

Exclusion criteria

Exclusion criteria: Female patients having pregnancy, breast feeding or post-delivery period. Patients with any reproductive tract malignancy. Patients with other systemic illness. Patients with positive history of venereal diseases Patients who are using CU-T or chemical method of contraception.

Design outcomes

Primary

Measure	Time frame
white discharge from vagina will reduceTimepoint: at 4 week	—

Secondary

Measure	Time frame
no reoccurrence of white dischargeTimepoint: 6 weeks	—

Countries

India

Contacts

Public ContactVaishali Dave

JS Ayurveda Mahavidyalaya

vaishalivasavda@gmail.com09662140078

Outcome results